APA (7th ed.) Citation

Almodallal, Y., Whitehurst, D., Way, S. S., Koo, J., & Kumar, A. R. (2025). Emapalumab for Maladaptive Interferon‐γ‐Mediated Inflammation in Drug Reaction With Eosinophilia and Systemic Symptoms Complicating First‐Line Antituberculosis Therapy. Wiley. https://doi.org/10.1002/pbc.32052

Chicago Style (17th ed.) Citation

Almodallal, Yahya, Daniel Whitehurst, Sing Sing Way, Jane Koo, and Ashish R. Kumar. Emapalumab for Maladaptive Interferon‐γ‐Mediated Inflammation in Drug Reaction With Eosinophilia and Systemic Symptoms Complicating First‐Line Antituberculosis Therapy. Wiley, 2025. https://doi.org/10.1002/pbc.32052.

MLA (9th ed.) Citation

Almodallal, Yahya, et al. Emapalumab for Maladaptive Interferon‐γ‐Mediated Inflammation in Drug Reaction With Eosinophilia and Systemic Symptoms Complicating First‐Line Antituberculosis Therapy. Wiley, 2025. https://doi.org/10.1002/pbc.32052.